SCHEMBL22360202

SCHEMBL22360202

OC[C@@H]1CCSS1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2230882 1.00
SCHEMBL30508486 0.79
SCHEMBL8183345 0.72
SCHEMBL29263924 0.72 HSD17B10 (0.67)
SCHEMBL4475727 0.72 HSD17B10 (0.59)
SCHEMBL7530608 0.72 HSD17B10 (0.59)
SCHEMBL18937977 0.69
SCHEMBL593240 0.69
SCHEMBL6809713 0.67 HSD17B10 (0.76)
SCHEMBL2733548 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220151988-A1 Choline Esters ENCORE HEALTH LLC 2022-05-19 US disclosed
US-11186561-B2 Compounds, compositions and methods for treatment of eye disorders and skin diseases CELLIX BIO PRIVATE LIMITED (IN) 2021-11-30 US disclosed
US-20200352903-A1 Choline Esters ENCORE HEALTH LLC 2020-11-12 US disclosed
US-20200262809-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT OF EYE DISORDERS AND SKIN DISEASES CELLIX BIO PRIVATE LTD (IN) 2020-08-20 US disclosed